ArticleNature communicationsPublished
Personalized targeting of BCL2 family proteins overcomes acquired resistance to BRAF-MEK inhibitors in preclinical melanoma
Regional connection
Verified An author affiliation on the Europe PMC record names The Wistar Institute. Affiliation source
- Institution
- The Wistar Institute
- County
- Philadelphia County
Publication record
- Type
- Article
- Venue
- Nature communications
- Published
- Topic
- Disease research
- Subject terms
- Cell Line, Tumor; Animals; Humans; Mice; Melanoma; Sulfonamides; Aniline Compounds; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-bcl-2; Protein Kinase Inhibitors; Xenograft Model Antitumor Assays; Drug Resistance, Neoplasm
- PubMed ID
- 42362544
- PubMed Central ID
- PMC13421458
- Open access
- Yes, open
- Added to directory
- Source checked